Imaging of Peritoneal Carcinomatosis From Ovarian Carcinoma Patients

Phase 1/2 Completed 10 enrolled Jules Bordet Institute

NaSingle-groupOpen-labelDiagnostic

Summary

The purpose of this study is to determine if NIF fluorescent imaging is an effective approach to detect the gross ovarian tumoral tissues and peritoneal implants in Ovarian cancer patients.

Timeline

Start: 2013-03
Primary completion: 2014-10
Completion: 2014-10

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Indocyanine Green	Diagnostic / imaging agent	0.25 mg/kg	Intravenous

Imaging of Peritoneal Carcinomatosis From Ovarian Carcinoma Patients

Summary

Timeline

Drugs

Indications